Breaking

Medication

4 stories

AllUNIQUEPHARMACEUTICALNOVONORDISKELILILLYAMGENFDAMERCKHEALTHPHARMACEUTICALSTGMCENVIRONMENT CANADAAKSTONPHARMACYTELANGANA DCAIMHDEAMHRAAMBLEPLASTICSURGERYAKSTON BIOSCIENCESTLCFFXNOWLIPFENDRAHSCPREP4ALLMEDSCAPEGSKFRACTYLHEALTHTRUMPRXTELEHEALTHGLENMARKMEDICAREEUROPEAN COMMISSIONHMSACVSCAR EMARKONCOLOGYKETABONPHARMACEUTICALLUPINLEQEMBIASCENSIONSAHPRAKENVUE
Medical professional reviewing clinical trial data on a tablet, focusing on drug safety and patient side effects.
ELILILLY6h ago

5 Retatrutide Side Effects: What We Know From Clinical Trials

Retatrutide is an investigational drug currently moving through clinical trials for weight loss. Because it is still in development, it lacks FDA approval and an official, final side effect profile. However, data from on

A stylized digital illustration of a syringe labeled with clinical markings against a background of social media icons.
1d ago

The Experimental Weight-Loss Peptide Spreading Among Teens

A stylized graphic showing a medical vial and syringe representing the unregulated use of experimental weight-loss drugs.
2d ago

The Experimental Weight-Loss Peptide Spreading Among Teens

Close-up of a medical professional checking the health records of an elderly patient in a clinical setting.
6d ago

Study flags need to monitor frailty risks with GLP-1 drugs for older adults

← BACK TO ALL HEALTH NEWS